0001209191-21-014434.txt : 20210225 0001209191-21-014434.hdr.sgml : 20210225 20210225180920 ACCESSION NUMBER: 0001209191-21-014434 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210224 FILED AS OF DATE: 20210225 DATE AS OF CHANGE: 20210225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: aMoon 2 Fund Limited Partnership CENTRAL INDEX KEY: 0001744099 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 21682359 BUSINESS ADDRESS: STREET 1: 34 YERUSHALAYIM RD. CITY: RAANANA STATE: L3 ZIP: 4350110 BUSINESS PHONE: 972(73)3989560 MAIL ADDRESS: STREET 1: 34 YERUSHALAYIM RD. CITY: RAANANA STATE: L3 ZIP: 4350110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schindel Yair Chaim CENTRAL INDEX KEY: 0001823758 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51531 FILM NUMBER: 21682358 MAIL ADDRESS: STREET 1: YERUSHALAYIM ROAD 34 STREET 2: BEIT GAMLA ENTRANCE B CITY: RA'ANANA STATE: L3 ZIP: 4350110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001061027 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943295878 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-3500 MAIL ADDRESS: STREET 1: 395 OYSTER POINT BOULEVARD STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19980709 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2021-02-24 0 0001061027 SUNESIS PHARMACEUTICALS INC VIRX 0001744099 aMoon 2 Fund Limited Partnership 34 YERUSHALAIM ROAD BEIT GAMLA, 6TH FLOOR RA-ANANA, 4350110 L3 ISRAEL 0 0 1 0 0001823758 Schindel Yair Chaim 34 YERUSHALAIM ROAD BEIT GAMLA, 6TH FLOOR RA-ANANA L3 ISRAEL 0 0 1 0 Common Stock 5359372 D Common Stock 2032865 I See Footnote The reported shares are held of record by aMoon 2 Fund, Limited Partnership ("aMoon 2 Fund"). aMoon 2 Fund G.P. Limited Partnership ("aMoon 2 Fund G.P.") is the sole General Partner of aMoon 2 Fund and aMoon General Partner Ltd. ("aMoon General Partner") is the sole General Partner of aMoon 2 Fund G.P. Dr. Yair Schindel is the sole shareholder of aMoon General Partner. By virtue of such relationships, aMoon 2 Fund G.P., aMoon General Partner and Dr. Schindel may be deemed to have shared voting and investment power with respect to the shares held of record by aMoon 2 Fund. Each of aMoon 2 Fund G.P., aMoon General Partner and Dr. Schindel disclaims beneficial ownership of the shares held by aMoon 2 Fund except to the extent of its or his pecuniary interest therein, if any. The reported shares are held of record by aMoon - VRCT SPV Limited Partnership ("aMoon - VRCT"). aMoon 2 Fund G.P. is the sole General Partner of aMoon - VRCT and aMoon General Partner is the sole General Partner of aMoon 2 Fund G.P. Dr. Schindel is the sole shareholder of aMoon General Partner. By virtue of such relationships, aMoon 2 Fund G.P., aMoon General Partner and Dr. Schindel may be deemed to have shared voting and investment power with respect to the shares held of record by aMoon - VRCT. Each of aMoon 2 Fund G.P., aMoon General Partner and Dr. Schindel disclaims beneficial ownership of the shares held by aMoon - VRCT except to the extent of its or his pecuniary interest therein, if any. /s/ Yair Schindel, the sole shareholder of aMoon General Partner Ltd., the sole General Partner of aMoon 2 Fund G.P. Limited Partnership, the sole General Partner of aMoon 2 Fund, Limited Partnership 2021-02-24 /s/ Yair Schindel 2021-02-24